malignant tissue samples; adjacent normal tissue samples
-
not specified
Microarray; RT-qPCR; RNase R Treatment; Sanger Sequencing; Clinical Sample Validation; ROC Analysis; Cohort Study; Survival Analysis
Discriminates malignant vs adjacent normal prostate tissue (AUC 0.780).
circCSNK1G3 is down-regulated in prostate cancer tissue and was assessed mainly for diagnostic discrimination and BCR association analyses; this study did not perform functional mechanism experiments for it.
0.6813
Circular RNAs and Their Linear Transcripts as Diagnostic and Prognostic Tissue Biomarkers in Prostate Cancer after Prostatectomy in Combination with Clinicopathological Factors.
combined biological and clinical study